The bioengineering company Ossium Health has created a new program that offers deep-frozen bone marrow from deceased organ donors -- and a Michigan woman has received the first transplant.
Trading remains a sell-the-rally environment, with resistance entrenched around $0.126 to $0.127 and only tentative, short-lived bounces emerging on intraday....